- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.12. | Bayer aims Mirena at women's health issue with no treatment | ||
| 02.12. | FDA doubles down on its push into AI | ||
| 02.12. | Slow recruitment still hitting UK trials, says pharma | ||
| 01.12. | UK and US agree zero tariffs on pharma - with price rises | ||
| 01.12. | EMA starts review of 'transformative' bladder cancer therapy | ||
| 01.12. | Belite plans filing for oral Stargardt drug after phase 3 win | ||
| 01.12. | Real-world trial of Lilly's tirzepatide starts in UK | ||
| 01.12. | Is FDA about to restrict vaccination even further? | ||
| 01.12. | Limited prostate cancer screening backed in UK | ||
| 28.11. | Veraxa says delayed US listing is back on track | ||
| 28.11. | Innovent gets OK for China's first home-grown IL-23p19 drug | ||
| 28.11. | Digital platform for GPs 'could transform clinical trials' | ||
| 28.11. | Wellcome donates £2m to UK's digital mental health drive | ||
| 28.11. | Tonix launches its new fibromyalgia drug in US | ||
| 27.11. | Wearable alert system for epileptics set for European launch | ||
| 27.11. | Vaderis drug lends hope to patients with bleeding disease HHT | ||
| 27.11. | Platform tests commercial algorithms for NHS use for bias | ||
| 27.11. | FDA starts priority review of BeOne's Venclexta rival | ||
| 27.11. | Lundbeck bows out of bidding war for Avadel | ||
| 26.11. | Novo Nordisk spends priority voucher on Wegovy filing | ||
| 26.11. | Sanofi's Paris HQ raided in tax fraud probe | ||
| 26.11. | Kelonia's in vivo CAR-T data will feature at ASH | ||
| 26.11. | Otsuka joins IgAN market with Voyxact approval in US | ||
| 26.11. | Latest Medicare pricing cuts promise $12bn in savings | ||
| 25.11. | Data sets up phase 3 trials for Novo's amycretin in diabetes |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .